Skip to content

Clinical trials

Recruiting Hemorrhage trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemorrhage Status: Recruiting Country / region: China Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20191
20221
20233
20259
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting20

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Beijing Tiantan Hospital2
Chinese Academy of Medical Sciences, Fuwai Hospital2
Second Affiliated Hospital, Zhejiang University, School of Medicine2
Takeda2
Beijing Anzhen Hospital1
Guangdong Provincial People's Hospital1
Jilin University1
Ningbo No. 1 Hospital1
Pfizer1
Population Health Research Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemorrhage20
Cerebral Hemorrhage3
Stroke3
Atrial Fibrillation2
Autoimmune Diseases2
Blood Platelet Disorders2
Cardiovascular Diseases2
Coronary Artery Disease2
Cytopenia2
Embolism and Thrombosis2

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.